HPV testing at Fujirebio

Since our founding in 1950, we have developed and provided trusted and innovative IVD testing solutions that empower healthcare professionals with accurate insights that allows for the most clinically dependable outcomes of patients – outcomes that affect their future.

Since the 1990's our molecular testing solutions have been recognized for their high quality. We have recently extended our molecular testing portfolio and are now pleased to also offer methylation testing technology. Methylation testing raises accuracy and reliability to an art form that can make a decisive difference in the lives of millions of patients across the world.

Our reliable and accurate solutions for molecular test laboratories today include:

  • Hepatitis B virus
  • Hepatitis C virus
  • Human papillomavirus  
  • Mycobacteria
  • Sexually transmitted infections
  • Urinary tract infections

Our portfolio of HPV testing solutions eases the burden on clinicians and patients, through improved screening, accurate triage, and identification of high-risk patients in need of treatment and through precise genotyping, when needed.

We have collected resources and reading material related to our HPV testing portfolio and offer below. Please feel free to contact us today if you were to have any questions or wish to discuss how we can collaborate.

 

Insights

Download our booklet about Improved HPV triage with FAM19A4/miR124-2 methylation analysis

How does FAM19A4/miR124-2 methylation analysis improve hrHPV positive patient triage and how does it allow a wait-and-see policy? This booklet guides you through some of the key questions you might be asking yourself around the methylation-based testing technology.

Download your copy now

Webinars

Webinar (01:00:20)

Webinar replay: First void urine & HPV genotyping - Two essential tools to monitor the impact of HPV vaccination programs

Download our booklet about Improved HPV triage with FAM19A4/miR124-2 methylation analysis

How does FAM19A4/miR124-2 methylation analysis improve hrHPV positive patient triage and how does it allow a wait-and-see policy? This booklet guides you through some of the key questions you might be asking yourself around the methylation-based testing technology.

Download your copy now

Download booklet